This inventor holds 2 USPTO granted patents. Top assignees: Agence Nationale De Valorisation De La Recherche (Anvar), National Institute of Health and Medical Research, Sanofi. Active years: 1980-1984.
Location History:
- Nancy, FR (1980)
- Paris, FR (1984)
Company Filing History:
1 out of 338 
1 out of 1,853 
1 out of 1,540 
Years Active: 1980-1984
Title: Genevieve Evin: Innovator in Peptide Derivatives
Introduction
Genevieve Evin is a prominent inventor based in Nancy, France. She has made significant contributions to the field of peptide derivatives, particularly in the context of medical applications. With a total of 2 patents, her work focuses on innovative solutions for health-related challenges.
Latest Patents
Genevieve Evin's latest patents include the development of acid-protease inhibiting peptide derivatives. This invention relates to peptide derivatives of a specific general formula. Additionally, she has created novel derivatives of pepstatin, which are characterized by a general formula where X, Y, and Z represent various amino acids. These derivatives are particularly useful in diagnosing and treating arterial hypertension due to the action of renin.
Career Highlights
Throughout her career, Genevieve has worked with notable organizations such as Agence Nationale De Valorisation De La Recherche (ANVAR) and Sanofi. Her experience in these companies has allowed her to advance her research and contribute to significant innovations in her field.
Collaborations
Genevieve has collaborated with esteemed colleagues, including Pierre Corvol and Bertrand Castro. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Genevieve Evin is a trailblazer in the field of peptide derivatives, with a focus on medical applications. Her innovative patents and collaborations highlight her commitment to advancing healthcare solutions.